515 A phase 1 study of myeloid modulating agent MTL-CEBPA in combination with pembrolizumab in adult patients with advanced solid tumours

by Ruth Plummer, Alessio Cortellini, Debashis Sarker, Ilian Tchakov, John Rossi, David Pinato, Mikael Sodergren, Vikash Reebye, Duncan Spalding, Nina Raulf, Laura Sinigaglia, Thomas Talbot, Antonio D’Alessio, Robert Habib, Nagy Habib
Published 2021-11-01

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers

by Xingfeng Bao, Andrea Varga, David S Hong, Aparna Parikh, Geoffrey I Shapiro, Özlem Ataman, Larisa Reyderman, Terri A Binder, Min Ren, Mingjie Liu, Satish Dayal, Amy Y Siu, Pallavi Sachdev, Lucy Xu, Vijay Bhagawati-Prasad, Ilian Tchakov, Chean Eng Ooi
Published 2020-06-01

679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or lat...

by Siqing Fu, Rom S Leidner, Ki Chung, Jiaxin Niu, Ilian Tchakov, Debra L Richardson, Xiaoping Qing, Jorge Nieva, Douglas Adkins, Alan L Ho, Minh Phan, Alexander T Pearson, Marshall R Posner, Lisle Nabell, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Trisha Kaufmann, Christopher Plescia, Corinne Iacobucci, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister
Published 2023-11-01